isatin has been researched along with thiazolyl blue in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glover, V; Igosheva, N; Lorz, C; Mehmet, H; O'Conner, E | 1 |
Calvo, TR; Cândido-Bacani, Pde M; Cólus, IM; Mori, MP; Varanda, EA; Vilegas, W | 1 |
2 other study(ies) available for isatin and thiazolyl blue
Article | Year |
---|---|
Isatin, an endogenous monoamine oxidase inhibitor, triggers a dose- and time-dependent switch from apoptosis to necrosis in human neuroblastoma cells.
Topics: Annexin A5; Antiparkinson Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isatin; Monoamine Oxidase Inhibitors; Necrosis; Neuroblastoma; Neurons; Neurotoxins; Parkinson Disease; Propidium; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
In vitro assessment of the cytotoxic, apoptotic, and mutagenic potentials of isatin.
Topics: Animals; Apoptosis; Cell Division; Cell Nucleus; Cell Survival; CHO Cells; Cricetinae; Cricetulus; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Isatin; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Plant Extracts; Plants, Medicinal; Tetrazolium Salts; Thiazoles | 2013 |